LSPN Spring North America 2025

The 7th Annual LSPN North America–Spring Conference took place at The Hyatt Regency Boston on May 6-7 2025, bringing together leading IP professionals from the pharmaceutical, biotechnology, and medtech sectors.

This essential event offered expert sessions, interactive panels, and roundtables focused on the latest legal developments and practical strategies shaping life sciences IP. With a strong presence of in-house counsel, the conference provided a unique opportunity to connect with peers and gain insights into patentability, prosecution, litigation, and more.

Brought to you by Life Sciences Intellectual Property Review, LSPN remains the premier event for those navigating life sciences IP challenges. Watch videos below featuring speakers from organisations such as BlueRock Therapeutics, Merck, BioNTech, Pfizer, and Radius Health.

WATCH: The transparency tightrope—balancing innovation, regulation, and IP protection in a new era

This LSPN panel features experts from Maiwald, Regeneron, Vertex Pharmaceuticals, and Taylor Wessing discussing the impact of increased transparency requirements in clinical trials and their effects on the global patent system. The session focuses on recent regulatory changes, especially in Europe, and the challenges they present for IP protection.

WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond

10 July 2025

WATCH: Policy direction—where are we now?

30 June 2025

LSPN Spring North America 2025

Get up-to-date information on all our publications and events